Workflow
KetoAir™ breathalyzer
icon
Search documents
Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
Globenewswire· 2025-06-26 12:00
Core Viewpoint - Avalon GloboCare Corp. has entered into a definitive agreement with Qi Diagnostics to co-develop a VOC nanosensor-based point-of-care cannabis breathalyzer aimed at enhancing public safety and supporting real-time detection of cannabis-impaired driving [1][2][3] Company Overview - Avalon GloboCare Corp. (NASDAQ: ALBT) specializes in precision diagnostic consumer products and is advancing intellectual property in cellular therapy [4] - The company is currently marketing the KetoAir™ breathalyzer device, which is registered with the U.S. Food and Drug Administration as a Class I medical device [4] Strategic Collaboration - The collaboration involves Avalon, its subsidiary Q&A Distribution, LLC, and Qi Diagnostics to jointly design, validate, and develop a prototype for the cannabis breathalyzer device [2] - This partnership aims to combine Avalon's regulatory expertise with Qi Diagnostics' VOC nanosensor technology to create a non-invasive cannabis detection solution [3] Public Health Impact - The cannabis breathalyzer is intended to support law enforcement and workplace safety by providing a real-time detection solution for cannabis impairment [3]
Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
GlobeNewswire News Room· 2025-06-26 12:00
FREEHOLD, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it entered into a definitive agreement with Qi Diagnostics Limited (“Qi Diagnostics”), a nanosensor-based diagnostic technologies company, to co-develop a VOC (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer. Through this strategic collaboration, Avalon, Q&A Distribution, LLC, a subsidi ...
Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement
Globenewswire· 2025-04-29 12:00
The closing of the transactions contemplated by the definitive agreement is subject to certain conditions, including, without limitation, the approval of the stockholders of Avalon and the approval by the Nasdaq Stock Market of the listing of YOOV following the closing of the Merger. About YOOV Group Holding Limited YOOV is an Artificial Intelligence-as-a-Service (AIaaS) platform specializing in intelligent business automation, integrating AI, process and data into one platform to make business operations e ...
Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir
Globenewswire· 2025-04-15 12:00
Avalon's KetoAir™ breathalyzer used to maintain progress for law enforcement to establish and meet their BrAce goals during the ongoing BrAce 4 Impact Challenge FREEHOLD, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, today announced the addition of SpecialtyHealth, Inc. ("SpecialtyHealth") — co-founded by Dr. EJ Greenwald, the pioneer of the ...
Avalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge Series
Newsfilter· 2025-04-01 13:00
Core Insights - Avalon GloboCare Corp. has partnered with Pounds Transformation Clinics to launch the "BrAce 4 Impact Challenge Series," utilizing the KetoAir™ breathalyzer as a motivational tool for weight management [1][5] - The inaugural challenge began on April 1, 2025, following a successful pilot program that concluded on March 18, 2025, demonstrating positive results for participants [2][5] - The KetoAir™ device measures breath acetone concentration, providing real-time feedback on ketosis status, which aids users in their weight loss journey [4][5] Company Overview - Avalon GloboCare Corp. is a commercial-stage company focused on developing precision diagnostic consumer products, including the KetoAir™ breathalyzer [6] - The company aims to expand its diagnostic applications of breathalyzer technology and also operates in the commercial real estate sector [6] Partnership Details - The partnership with Pounds Transformation Clinics is designed to enhance patient engagement and support through dedicated coaching and real-time tracking of ketone levels [2][5] - Dr. Charles Cavo, a key figure in the partnership, reported significant weight loss results among participants using the KetoAir™ device, indicating its effectiveness in promoting accountability and motivation [2][5] Product Information - The KetoAir™ breathalyzer is FDA registered and utilizes nano-sensor technology to assess ketosis, available for download on both Apple and Google platforms [4] - The device has been integrated into Pounds Transformation's programs, allowing patients to monitor their health and progress effectively [5]